Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Follicular × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Colorectal Neoplasms 2 Resectable Localized Prostate Cancer 1 Recurrence 1 Radiation-induced Oral Mucositis 1 Prostate Cancer Recurrent 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 20 Rituximab 16 Lenalidomide 14 obinutuzumab 13 fludarabine 11 zanubrutinib 10 Bendamustine Hydrochloride 10 Magnetic Resonance Spectroscopy 9 Prednisone 8 Vincristine 7 Specimen Handling 7 Doxorubicin 7 fludarabine phosphate 6 tazemetostat 4 Radiotherapy 4 Biopsy 4 venetoclax 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 tisagenlecleucel 2 pirtobrutinib 2 loncastuximab tesirine 2 ibrutinib 2 Waiting Lists 2 Prednisolone 2 Mycophenolic Acid 2 Leukapheresis 2 Immunotherapy, Adoptive 2 Cyclosporine 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06739759 2024-12-18

OHSS

Aljazeera Hospital

Phase NA Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡